Search results
The Zacks Analyst Blog Highlights Alphabet, NVIDIA, Micron Technology, Vistra and CenterPoint Energy
Zacks· 1 day ago(GOOGL Quick QuoteGOOGL - Free Report) , NVIDIA Corporation (NVDA Quick QuoteNVDA - Free Report) , Micron Technology, Inc. (MU Quick QuoteMU - Free Report) , Vistra Corp.
Is It Too Late to Buy Micron Stock? | The Motley Fool
The Motley Fool· 2 days agoMicron's stock has surged, but is there still room for growth?
Micron Technology (NASDAQ:MU) Shares Gap Up After Analyst Upgrade
ETF DAILY NEWS· 4 days agoMicron Technology, Inc. (NASDAQ:MU – Get Free Report) shares gapped up before the market opened on Monday after Cantor Fitzgerald raised their price target on the
Pure Storage Stock: AI, Cloud Opportunity In Focus After Analyst Day
Investor's Business Daily· 20 hours agoPure Storage stock traded lower Friday despite positive takeaways from Wall Street analysts...
Micron stock price target lifted to $170 at Wedbush ahead of Q3 report By Investing.com
Investing.com· 4 days ago“In our view, the primary question with MU is history suggests the stock is expensive vs. asset...
Stocks to watch next week: Nike, AO World, H&M and Currys
Yahoo Finance UK· 1 day ago...Prosus (PRX.AS) Trigano (TRIP.XC) Tuesday 25 June FedEx (FDX) Carnival (CCL) Wednesday 26 June...
PLTR, MBIO, DKNG, MU, TSLA: Top Trending Stocks Today - DraftKings (NASDAQ:DKNG), Mustang Bio...
Benzinga· 4 days agoOn Monday, major U.S. indices saw gains, with the Dow Jones Industrial Average closing nearly 0.5%...
BofA raises target on Micron Technology stock to $170: Can it reach there? | Invezz
Invezz· 5 days agoMicron Technology Inc. (NASDAQ: MU) recently received a significant boost as Bank of America (BofA)...
Is Micron (MU) Likely to Beat Estimates This Earnings Season?
Zacks· 2 days agoFree Report) is likely to beat expectations when it reports third-quarter fiscal 2024 results after market close on Jun 26. The Zacks Consensus Estimate for the bottom line is pegged at 48 cents ...
Futures: AI Stocks Add To Losses
Investor's Business Daily· 24 hours agoSarepta Therapeutics surged Friday on FDA approval.